Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Intravenous Immunoglobulins market report explains the definition, types, applications, major countries, and major players of the Intravenous Immunoglobulins market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
LFB Group
Bharat Serum and Vaccines
Kedrion Biopharma
Hualan Biological Engineering
Sanquin
Bayer
Grifols
Biotest
Octapharma
China Biologic Products
CSL Behring
Shire
ADMA Biologics
By Type:
Neurology Intravenous Immunoglobulins
Hematology Intravenous Immunoglobulins
Immunology Intravenous Immunoglobulins
By End-User:
Primary Immunodeficiency
Idiopathic Thrombocytopenic Purpura
Chronic Inflammatory Demyelinating Polyneuropathy
Kawasaki Disease
Guillain-Barre Syndrome
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Intravenous Immunoglobulins Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Intravenous Immunoglobulins Outlook to 2028- Original Forecasts
-
2.2 Intravenous Immunoglobulins Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Intravenous Immunoglobulins Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Intravenous Immunoglobulins Market- Recent Developments
-
6.1 Intravenous Immunoglobulins Market News and Developments
-
6.2 Intravenous Immunoglobulins Market Deals Landscape
7 Intravenous Immunoglobulins Raw Materials and Cost Structure Analysis
-
7.1 Intravenous Immunoglobulins Key Raw Materials
-
7.2 Intravenous Immunoglobulins Price Trend of Key Raw Materials
-
7.3 Intravenous Immunoglobulins Key Suppliers of Raw Materials
-
7.4 Intravenous Immunoglobulins Market Concentration Rate of Raw Materials
-
7.5 Intravenous Immunoglobulins Cost Structure Analysis
-
7.5.1 Intravenous Immunoglobulins Raw Materials Analysis
-
7.5.2 Intravenous Immunoglobulins Labor Cost Analysis
-
7.5.3 Intravenous Immunoglobulins Manufacturing Expenses Analysis
8 Global Intravenous Immunoglobulins Import and Export Analysis (Top 10 Countries)
-
8.1 Global Intravenous Immunoglobulins Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Intravenous Immunoglobulins Export by Region (Top 10 Countries) (2017-2028)
9 Global Intravenous Immunoglobulins Market Outlook by Types and Applications to 2022
-
9.1 Global Intravenous Immunoglobulins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Neurology Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hematology Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunology Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
9.2 Global Intravenous Immunoglobulins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Primary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Idiopathic Thrombocytopenic Purpura Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Chronic Inflammatory Demyelinating Polyneuropathy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Kawasaki Disease Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Guillain-Barre Syndrome Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Intravenous Immunoglobulins Market Analysis and Outlook till 2022
-
10.1 Global Intravenous Immunoglobulins Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Intravenous Immunoglobulins Consumption (2017-2022)
-
10.2.2 Canada Intravenous Immunoglobulins Consumption (2017-2022)
-
10.2.3 Mexico Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.2 UK Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.3 Spain Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.4 Belgium Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.5 France Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.6 Italy Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.7 Denmark Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.8 Finland Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.9 Norway Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.10 Sweden Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.11 Poland Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.12 Russia Intravenous Immunoglobulins Consumption (2017-2022)
-
10.3.13 Turkey Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.2 Japan Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.3 India Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.4 South Korea Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.5 Pakistan Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.6 Bangladesh Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.7 Indonesia Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.8 Thailand Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.9 Singapore Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.10 Malaysia Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.11 Philippines Intravenous Immunoglobulins Consumption (2017-2022)
-
10.4.12 Vietnam Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5.2 Colombia Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5.3 Chile Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5.4 Argentina Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5.5 Venezuela Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5.6 Peru Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5.7 Puerto Rico Intravenous Immunoglobulins Consumption (2017-2022)
-
10.5.8 Ecuador Intravenous Immunoglobulins Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Intravenous Immunoglobulins Consumption (2017-2022)
-
10.6.2 Kuwait Intravenous Immunoglobulins Consumption (2017-2022)
-
10.6.3 Oman Intravenous Immunoglobulins Consumption (2017-2022)
-
10.6.4 Qatar Intravenous Immunoglobulins Consumption (2017-2022)
-
10.6.5 Saudi Arabia Intravenous Immunoglobulins Consumption (2017-2022)
-
10.6.6 United Arab Emirates Intravenous Immunoglobulins Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Intravenous Immunoglobulins Consumption (2017-2022)
-
10.7.2 South Africa Intravenous Immunoglobulins Consumption (2017-2022)
-
10.7.3 Egypt Intravenous Immunoglobulins Consumption (2017-2022)
-
10.7.4 Algeria Intravenous Immunoglobulins Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Intravenous Immunoglobulins Consumption (2017-2022)
-
10.8.2 New Zealand Intravenous Immunoglobulins Consumption (2017-2022)
11 Global Intravenous Immunoglobulins Competitive Analysis
-
11.1 LFB Group
-
11.1.1 LFB Group Company Details
-
11.1.2 LFB Group Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 LFB Group Intravenous Immunoglobulins Main Business and Markets Served
-
11.1.4 LFB Group Intravenous Immunoglobulins Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bharat Serum and Vaccines
-
11.2.1 Bharat Serum and Vaccines Company Details
-
11.2.2 Bharat Serum and Vaccines Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bharat Serum and Vaccines Intravenous Immunoglobulins Main Business and Markets Served
-
11.2.4 Bharat Serum and Vaccines Intravenous Immunoglobulins Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Kedrion Biopharma
-
11.3.1 Kedrion Biopharma Company Details
-
11.3.2 Kedrion Biopharma Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Kedrion Biopharma Intravenous Immunoglobulins Main Business and Markets Served
-
11.3.4 Kedrion Biopharma Intravenous Immunoglobulins Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Hualan Biological Engineering
-
11.4.1 Hualan Biological Engineering Company Details
-
11.4.2 Hualan Biological Engineering Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Hualan Biological Engineering Intravenous Immunoglobulins Main Business and Markets Served
-
11.4.4 Hualan Biological Engineering Intravenous Immunoglobulins Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Sanquin
-
11.5.1 Sanquin Company Details
-
11.5.2 Sanquin Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Sanquin Intravenous Immunoglobulins Main Business and Markets Served
-
11.5.4 Sanquin Intravenous Immunoglobulins Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bayer
-
11.6.1 Bayer Company Details
-
11.6.2 Bayer Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bayer Intravenous Immunoglobulins Main Business and Markets Served
-
11.6.4 Bayer Intravenous Immunoglobulins Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Grifols
-
11.7.1 Grifols Company Details
-
11.7.2 Grifols Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Grifols Intravenous Immunoglobulins Main Business and Markets Served
-
11.7.4 Grifols Intravenous Immunoglobulins Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Biotest
-
11.8.1 Biotest Company Details
-
11.8.2 Biotest Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Biotest Intravenous Immunoglobulins Main Business and Markets Served
-
11.8.4 Biotest Intravenous Immunoglobulins Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Octapharma
-
11.9.1 Octapharma Company Details
-
11.9.2 Octapharma Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Octapharma Intravenous Immunoglobulins Main Business and Markets Served
-
11.9.4 Octapharma Intravenous Immunoglobulins Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 China Biologic Products
-
11.10.1 China Biologic Products Company Details
-
11.10.2 China Biologic Products Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 China Biologic Products Intravenous Immunoglobulins Main Business and Markets Served
-
11.10.4 China Biologic Products Intravenous Immunoglobulins Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 CSL Behring
-
11.11.1 CSL Behring Company Details
-
11.11.2 CSL Behring Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 CSL Behring Intravenous Immunoglobulins Main Business and Markets Served
-
11.11.4 CSL Behring Intravenous Immunoglobulins Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Shire
-
11.12.1 Shire Company Details
-
11.12.2 Shire Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Shire Intravenous Immunoglobulins Main Business and Markets Served
-
11.12.4 Shire Intravenous Immunoglobulins Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 ADMA Biologics
-
11.13.1 ADMA Biologics Company Details
-
11.13.2 ADMA Biologics Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 ADMA Biologics Intravenous Immunoglobulins Main Business and Markets Served
-
11.13.4 ADMA Biologics Intravenous Immunoglobulins Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Intravenous Immunoglobulins Market Outlook by Types and Applications to 2028
-
12.1 Global Intravenous Immunoglobulins Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Neurology Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Hematology Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Immunology Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Intravenous Immunoglobulins Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Primary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Idiopathic Thrombocytopenic Purpura Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Chronic Inflammatory Demyelinating Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Kawasaki Disease Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Guillain-Barre Syndrome Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Intravenous Immunoglobulins Market Analysis and Outlook to 2028
-
13.1 Global Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.2.2 Canada Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.2.3 Mexico Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.2 UK Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.3 Spain Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.4 Belgium Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.5 France Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.6 Italy Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.7 Denmark Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.8 Finland Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.9 Norway Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.10 Sweden Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.11 Poland Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.12 Russia Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.13 Turkey Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.2 Japan Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.3 India Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.4 South Korea Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.8 Thailand Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.9 Singapore Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.11 Philippines Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.2 Colombia Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.3 Chile Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.4 Argentina Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.6 Peru Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.3 Oman Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.4 Qatar Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7.2 South Africa Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7.3 Egypt Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7.4 Algeria Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Intravenous Immunoglobulins Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Intravenous Immunoglobulins Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Intravenous Immunoglobulins
-
Figure of Intravenous Immunoglobulins Picture
-
Table Global Intravenous Immunoglobulins Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Intravenous Immunoglobulins Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Neurology Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Global Hematology Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Global Immunology Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
Figure Global Idiopathic Thrombocytopenic Purpura Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Inflammatory Demyelinating Polyneuropathy Consumption and Growth Rate (2017-2022)
-
Figure Global Kawasaki Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Guillain-Barre Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Table North America Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Figure United States Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Canada Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Mexico Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Europe Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Germany Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure UK Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Spain Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Belgium Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure France Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Italy Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Denmark Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Finland Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Norway Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Sweden Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Poland Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Russia Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Turkey Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table APAC Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Figure China Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Japan Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure India Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Thailand Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Singapore Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Philippines Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table South America Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Brazil Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Colombia Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Chile Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Argentina Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Peru Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table GCC Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Bahrain Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Oman Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Qatar Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Africa Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Nigeria Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure South Africa Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Egypt Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Algeria Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Oceania Intravenous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Australia Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Intravenous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table LFB Group Company Details
-
Table LFB Group Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table LFB Group Intravenous Immunoglobulins Main Business and Markets Served
-
Table LFB Group Intravenous Immunoglobulins Product Portfolio
-
Table Bharat Serum and Vaccines Company Details
-
Table Bharat Serum and Vaccines Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bharat Serum and Vaccines Intravenous Immunoglobulins Main Business and Markets Served
-
Table Bharat Serum and Vaccines Intravenous Immunoglobulins Product Portfolio
-
Table Kedrion Biopharma Company Details
-
Table Kedrion Biopharma Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Biopharma Intravenous Immunoglobulins Main Business and Markets Served
-
Table Kedrion Biopharma Intravenous Immunoglobulins Product Portfolio
-
Table Hualan Biological Engineering Company Details
-
Table Hualan Biological Engineering Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Biological Engineering Intravenous Immunoglobulins Main Business and Markets Served
-
Table Hualan Biological Engineering Intravenous Immunoglobulins Product Portfolio
-
Table Sanquin Company Details
-
Table Sanquin Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanquin Intravenous Immunoglobulins Main Business and Markets Served
-
Table Sanquin Intravenous Immunoglobulins Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Intravenous Immunoglobulins Main Business and Markets Served
-
Table Bayer Intravenous Immunoglobulins Product Portfolio
-
Table Grifols Company Details
-
Table Grifols Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Intravenous Immunoglobulins Main Business and Markets Served
-
Table Grifols Intravenous Immunoglobulins Product Portfolio
-
Table Biotest Company Details
-
Table Biotest Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest Intravenous Immunoglobulins Main Business and Markets Served
-
Table Biotest Intravenous Immunoglobulins Product Portfolio
-
Table Octapharma Company Details
-
Table Octapharma Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Intravenous Immunoglobulins Main Business and Markets Served
-
Table Octapharma Intravenous Immunoglobulins Product Portfolio
-
Table China Biologic Products Company Details
-
Table China Biologic Products Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Biologic Products Intravenous Immunoglobulins Main Business and Markets Served
-
Table China Biologic Products Intravenous Immunoglobulins Product Portfolio
-
Table CSL Behring Company Details
-
Table CSL Behring Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Intravenous Immunoglobulins Main Business and Markets Served
-
Table CSL Behring Intravenous Immunoglobulins Product Portfolio
-
Table Shire Company Details
-
Table Shire Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Intravenous Immunoglobulins Main Business and Markets Served
-
Table Shire Intravenous Immunoglobulins Product Portfolio
-
Table ADMA Biologics Company Details
-
Table ADMA Biologics Intravenous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table ADMA Biologics Intravenous Immunoglobulins Main Business and Markets Served
-
Table ADMA Biologics Intravenous Immunoglobulins Product Portfolio
-
Figure Global Neurology Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematology Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunology Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Idiopathic Thrombocytopenic Purpura Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Inflammatory Demyelinating Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kawasaki Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Guillain-Barre Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Table North America Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure United States Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Germany Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure China Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Brazil Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Australia Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Intravenous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
